These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dynamic restoration of dystrophin to dystrophin-deficient myotubes. Kong J; Anderson JE Muscle Nerve; 2001 Jan; 24(1):77-88. PubMed ID: 11150969 [TBL] [Abstract][Full Text] [Related]
8. Modulation by prednisolone of calcium handling in skeletal muscle cells. Metzinger L; Passaquin AC; Leijendekker WJ; Poindron P; Rüegg UT Br J Pharmacol; 1995 Dec; 116(7):2811-6. PubMed ID: 8680710 [TBL] [Abstract][Full Text] [Related]
9. Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Passaquin AC; Lhote P; Rüegg UT Br J Pharmacol; 1998 Aug; 124(8):1751-9. PubMed ID: 9756393 [TBL] [Abstract][Full Text] [Related]
10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
11. [Duchenne Boulogne myopathy and free radicals; potential value of lazaroids in the treatment of this disease]. Poindron P; Metzinger L; Warter JM C R Seances Soc Biol Fil; 1995; 189(6):1199-217. PubMed ID: 8763042 [No Abstract] [Full Text] [Related]
12. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice. Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413 [TBL] [Abstract][Full Text] [Related]
13. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
14. Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study. Mader N; Gilly H; Bittner RE Br J Anaesth; 1997 Jul; 79(1):125-7. PubMed ID: 9301401 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy. Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938 [TBL] [Abstract][Full Text] [Related]
16. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850 [TBL] [Abstract][Full Text] [Related]
18. The absence of dystrophin rather than muscle degeneration causes acetylcholine receptor cluster defects in dystrophic muscle. Kong J; Yang L; Li Q; Cao J; Yang J; Chen F; Wang Y; Zhang C Neuroreport; 2012 Jan; 23(2):82-7. PubMed ID: 22124255 [TBL] [Abstract][Full Text] [Related]
19. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Mueller GM; O'Day T; Watchko JF; Ontell M Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro. Durmaz R; Deliorman S; Isiksoy S; Uyar R; Erol K; Tel E Pathol Oncol Res; 1999; 5(3):223-8. PubMed ID: 10491022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]